GH Research announces annual general meeting for July 31

GH Research PLC (NASDAQ:GHRS) has scheduled its annual general meeting for July 31, 2025, at 2:00 P.M. Irish Standard Time. The meeting will take place at the company’s headquarters at Joshua Dawson House in Dublin, Ireland. The company’s stock, currently trading at $21.10, has seen a challenging year with a -37% return over the past 12 months. According to InvestingPro, the company maintains a "GOOD" overall Financial Health score.

The pharmaceutical company made the announcement today through an SEC filing, where it disclosed that a convening notice has been made available to shareholders. The filing includes several exhibits related to the meeting, including the official notice, the company’s 2024 Irish Statutory Financial Statements, agenda information, and proxy materials. Investors should note that GH Research’s next earnings report is scheduled for August 29, 2025.

Shareholders will have access to proxy cards, with separate versions provided for record holders and those who hold shares through brokers. The company has also issued notices regarding the availability of proxy materials and agenda items to be discussed at the meeting.

The filing was signed by Julie Ryan, Vice President of Finance at GH Research PLC.

GH Research, which specializes in pharmaceutical preparations, trades on the Nasdaq under the ticker GHRS and files its annual reports under Form 20-F as indicated in the SEC document.

In other recent news, Coca-Cola (NYSE:KO) Europacific Partners has been actively engaged in a share buyback program, purchasing its own shares across multiple trading venues, including the US and London, between June 4 and June 9, 2025. These repurchased shares are set to be canceled, aligning with the company’s strategy to enhance shareholder value. MAG Silver Corp (TSX:MAG). announced significant amendments to its arrangement agreement, which could affect its operations and future strategies. Pan American Silver Corp (NYSE:PAAS). also reported amendments to its agreements with MAG Silver (NYSE:MAG), highlighting potential impacts on their strategic direction. LATAM Airlines (NYSE:LTM) Group entered into an underwriting agreement with J.P. Morgan Securities LLC for the sale of common shares, marking a continuation of its financial activities. Sinovac Biotech has scheduled a special shareholder meeting on July 8, 2025, though specific agenda items have not been disclosed. These developments reflect ongoing strategic and financial maneuvers by these companies, providing investors with crucial insights into their current activities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.